85 related articles for article (PubMed ID: 14555868)
1. Subjective effects of antidepressants: a pilot study of the varieties of antidepressant-induced experiences in meditators.
Bitner R; Hillman L; Victor B; Walsh R
J Nerv Ment Dis; 2003 Oct; 191(10):660-7. PubMed ID: 14555868
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
Pae CU; Mandelli L; Kim TS; Han C; Masand PS; Marks DM; Patkar AA; Steffens DC; De Ronchi D; Serretti A
Biomed Pharmacother; 2009 Mar; 63(3):228-35. PubMed ID: 18502089
[TBL] [Abstract][Full Text] [Related]
3. Pain sensitivity and analgesic effects of mindful states in Zen meditators: a cross-sectional study.
Grant JA; Rainville P
Psychosom Med; 2009 Jan; 71(1):106-14. PubMed ID: 19073756
[TBL] [Abstract][Full Text] [Related]
4. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.
Sato Y; Yasui-Furukori N; Nakagami T; Saito M; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):416-8. PubMed ID: 19166896
[TBL] [Abstract][Full Text] [Related]
6. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
Emslie GJ; Ryan ND; Wagner KD
J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
[TBL] [Abstract][Full Text] [Related]
7. A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.
Witkin JM; Tzavara ET; Davis RJ; Li X; Nomikos GG
Trends Pharmacol Sci; 2005 Dec; 26(12):609-17. PubMed ID: 16260047
[TBL] [Abstract][Full Text] [Related]
8. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
[TBL] [Abstract][Full Text] [Related]
9. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
10. Committee for Medicinal Products for Human Use (CHMP) assessment on efficacy of antidepressants.
Broich K;
Eur Neuropsychopharmacol; 2009 May; 19(5):305-8. PubMed ID: 19269795
[TBL] [Abstract][Full Text] [Related]
11. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
12. Orthostatic side effects of clomipramine and moclobemide during treatment for depression.
Stage KB;
Nord J Psychiatry; 2005; 59(4):298-301. PubMed ID: 16195134
[TBL] [Abstract][Full Text] [Related]
13. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
Ghaemi SN
Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
[TBL] [Abstract][Full Text] [Related]
15. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
16. Awareness of subtle emotional feelings: a comparison of long-term meditators and nonmeditators.
Nielsen L; Kaszniak AW
Emotion; 2006 Aug; 6(3):392-405. PubMed ID: 16938081
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant treatment-associated behavioural expression of hypomania: a case series.
Ramasubbu R
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1201-7. PubMed ID: 15610935
[TBL] [Abstract][Full Text] [Related]
18. Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.
Feighner JP; Sverdlov L; Hlavka J; Nicolau G; Cartwright K; Freed JS
Int Clin Psychopharmacol; 2008 Jan; 23(1):29-35. PubMed ID: 18090505
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in antidepressant therapy in special populations.
Hayes D
Am J Manag Care; 2004 Jul; 10(6 Suppl):S179-85. PubMed ID: 15354675
[TBL] [Abstract][Full Text] [Related]
20. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
